Cholesterol is a structural component of the cell and is indispensable for normal cellular function, although its excess often leads to abnormal proliferation, migration, inflammatory responses and/ or cell death. To prevent cholesterol overload, ATP-binding cassette (ABC) transporters mediate cholesterol efflux from the cells to apolipoprotein A-I (apoA-I) and the apoA-I-containing high-density lipoprotein (HDL) 1-3 . Maintaining efficient cholesterol efflux is essential for normal cellular function 4-6 . However, the role of cholesterol efflux in angiogenesis and the identity of its local regulators are poorly understood. Here we show that apoA-I binding protein (AIBP) accelerates cholesterol efflux from endothelial cells to HDL and thereby regulates angiogenesis. AIBP-and HDL-mediated cholesterol depletion reduces lipid rafts, interferes with VEGFR2 (also known as KDR) dimerization and signalling and inhibits vascular endothelial growth factor-induced angiogenesis in vitro and mouse aortic neovascularization ex vivo. Notably, Aibp, a zebrafish homologue of human AIBP, regulates the membrane lipid order in embryonic zebrafish vasculature and functions as a non-cell-autonomous regulator of angiogenesis. aibp knockdown results in dysregulated sprouting/branching angiogenesis, whereas forced Aibp expression inhibits angiogenesis. Dysregulated angiogenesis is phenocopied in Abca1 (also known as Abca1a) Abcg1-deficient embryos, and cholesterol levels are increased in Aibpdeficient and Abca1 Abcg1-deficient embryos. Our findings demonstrate that secreted AIBP positively regulates cholesterol efflux from endothelial cells and that effective cholesterol efflux is critical for proper angiogenesis.
Cholesterol is a structural component of the cell and is indispensable for normal cellular function, although its excess often leads to abnormal proliferation, migration, inflammatory responses and/ or cell death. To prevent cholesterol overload, ATP-binding cassette (ABC) transporters mediate cholesterol efflux from the cells to apolipoprotein A-I (apoA-I) and the apoA-I-containing high-density lipoprotein (HDL) 1-3 . Maintaining efficient cholesterol efflux is essential for normal cellular function [4] [5] [6] . However, the role of cholesterol efflux in angiogenesis and the identity of its local regulators are poorly understood. Here we show that apoA-I binding protein (AIBP) accelerates cholesterol efflux from endothelial cells to HDL and thereby regulates angiogenesis. AIBP-and HDL-mediated cholesterol depletion reduces lipid rafts, interferes with VEGFR2 (also known as KDR) dimerization and signalling and inhibits vascular endothelial growth factor-induced angiogenesis in vitro and mouse aortic neovascularization ex vivo. Notably, Aibp, a zebrafish homologue of human AIBP, regulates the membrane lipid order in embryonic zebrafish vasculature and functions as a non-cell-autonomous regulator of angiogenesis. aibp knockdown results in dysregulated sprouting/branching angiogenesis, whereas forced Aibp expression inhibits angiogenesis. Dysregulated angiogenesis is phenocopied in Abca1 (also known as Abca1a) Abcg1-deficient embryos, and cholesterol levels are increased in Aibpdeficient and Abca1 Abcg1-deficient embryos. Our findings demonstrate that secreted AIBP positively regulates cholesterol efflux from endothelial cells and that effective cholesterol efflux is critical for proper angiogenesis.
AIBP is a secreted protein that was discovered in a screen of proteins that physically associate with apoA-I 7 . Human APOA1BP mRNA encoding the AIBP protein is ubiquitously expressed 7 . Although AIBP binding to apoA-I implies that AIBP may modulate HDL function 7, 8 , its role in cholesterol efflux has not been experimentally tested.
First, we investigated whether human AIBP had any effect on cholesterol removal from human umbilical vein endothelial cells (HUVECs), in which ABCG1 is a key transporter responsible for cholesterol efflux {Deceased. HUVECs were transfected with control or ABCG1 siRNA, preloaded with 3 H-cholesterol and incubated for 1 h with 50 mg ml 21 HDL 3 in the presence or absence of 0.2 mg ml 21 AIBP. Efflux was measured as the 3 H counts in the medium divided by the sum of 3 H counts in the medium and the cells. Mean 6 s.e.; n 5 6. b, c, Effect of human AIBP on HDL 3 binding to HUVECs. HUVECs were incubated on ice with the indicated concentration of biotinylated HDL 3 (b-HDL 3 ), in the presence or absence of AIBP (at a 0.1:50 (w/w) AIBP:HDL 3 ratio) and 403 excess of unlabelled HDL. Each data point is mean 6 s.e. from 3 to 7 independent experiments. The binding parameters for b-HDL 3 -HUVEC binding were calculated as B max 5 0.8 6 0.1 and K d 5 (0.33 6 0.10) 3 10 26 M in absence of AIBP (panel b; R 2 5 0.92, Sy.x 5 0.1) and B max 5 1.5 6 0.4 and K d 5 (1.03 6 0.5) 3 10 26 M in the presence of AIBP (panel c; R 2 5 0.94, Sy.x 5 0.1). The differences in B max and K d values were statistically significant (P , 0.01 and P , 0.05, respectively). d, Effect of human AIBP and HDL 3 on endothelial cell tube formation.
HUVECs were pre-incubated with or without 50 mg ml 21 HDL 3 1 0.1 mg ml 21 AIBP for 4 h. Cells were then seeded on Matrigel, in the presence or absence of 20 ng ml 21 VEGF, and imaged following a 12-h incubation. Scale bar, 100 mm. e, The length of endothelial cell tubes in the experiment illustrated in d and Supplementary Fig. 4 . Mean 6 s.e.; n 5 5. f, Requirement for ABCG1 in human AIBP inhibition of angiogenesis. HUVECs were transfected with control or ABCG1 siRNA and assayed as in d. Mean 6 s.e.; n 5 6. g, Mouse aortic ring angiogenesis assay. Aortic rings from C57BL/6 wild-type (WT) and Abcg1 2/2 mice were embedded in Matrigel. Human HEK293 cells transiently expressing mCherry, zebrafish Aibp2 or human AIBP were inserted approximately 0.5 mm away from the aortic ring, and the plates were incubated with 10 ng ml 21 VEGF for 7 days. Images show the edge of the aortic rings facing the HEK293 cell clusters. Immunoblots show expression of AIBP and Aibp2 (both detected with a Flag tag antibody) and mCherry in HEK293 cells. h, The length of aortic ring sprouts. Mean 6 s.e.; n 5 10. NS, not significant. *P , 0.05, **P , 0.01, ***P , 0.001. to HDL 9, 10 . In the presence of AIBP, cholesterol efflux from HUVECs to HDL 3 (a subfraction of HDL, which is an efficient cholesterol acceptor) was increased twofold, an effect completely abrogated by ABCG1 deficiency ( Fig. 1a and Supplementary Fig. 2 ). AIBP did not promote cholesterol efflux in the absence of HDL 3 ( Supplementary Fig. 2b ), but the binding of AIBP to HUVECs ( Supplementary Fig. 3 ) increased the overall HUVEC capacity to bind HDL 3 (B max 5 1.5 versus 0.8) and the constant of HDL 3 dissociation from HUVECs (K d 5 1.0 3 10 26 M versus 0.33 3 10 26 M; Fig. 1b, c) , thereby creating conditions that would facilitate HDL 3 -mediated cholesterol efflux.
To investigate the role of AIBP-and HDL-mediated cholesterol efflux in angiogenesis, we incubated HUVECs with AIBP and/or HDL 3 and then stimulated cells with vascular endothelial growth factor (VEGF). AIBP and HDL 3 added separately did not affect endothelial cell tube formation, but together they significantly reduced angiogenesis ( Fig. 1d , e and Supplementary Fig. 4 ). Cholesterol depletion by methylb-cyclodextrin (MbCD) 11 also inhibited angiogenesis, whereas cholesterolloaded MbCD, which delivers cholesterol to the cell, promoted angiogenesis ( Supplementary Fig. 5 ). If the AIBP-and HDL 3 -mediated inhibition of angiogenesis is the consequence of accelerated cholesterol efflux, then this effect should depend on the presence of the cholesterol transporter ABCG1. Indeed, knockdown of ABCG1 in HUVECs rescued VEGF-induced angiogenesis from the AIBP-and HDL 3 -mediated inhibition ( Fig. 1f ). Further, we tested both human AIBP and a zebrafish AIBP homologue, here termed Aibp2 (discussed in more detail below), in an ex vivo aortic ring angiogenesis assay. A cluster of HEK293 cells producing either AIBP, Aibp2 or mCherry (used as a negative control) was placed 0.5 mm from the edge of a mouse aortic ring, and VEGF was added to stimulate angiogenesis. Both AIBP and Aibp2, but not mCherry, significantly reduced neovascularization of aortic rings isolated from a wild-type mouse ( Fig. 1g , h). Aortic rings from an Abcg1 2/2 mouse responded to VEGF with a more vigorous angiogenesis, which was not significantly reduced by AIBP or Aibp2. These results support the hypothesis that cholesterol efflux is necessary for the AIBP-mediated inhibition of angiogenesis.
HDL-mediated depletion of cholesterol from plasma membrane disrupts cholesterol-and sphingomyelin-rich membrane microdomains 12, 13 , often designated as lipid rafts, and affects membrane receptor signalling 11 . We found that human AIBP and HDL 3 reduced the lipid raft content in HUVECs and disrupted cell-surface co-localization of caveolin 1 (CAV1) and VEGFR2 ( Fig. 2a-c and Supplementary Fig. 6 ). The AIBP/HDL 3 treatment, similarly to the treatment with MbCD, decreased VEGFR2 and CAV1 localization to the lipid raft fraction isolated from cell lysates ( Fig. 2d and Supplementary Fig. 7 ). Many studies suggest that VEGFR2 localization to lipid rafts facilitates VEGFR2 dimerization and endocytosis [14] [15] [16] [17] , the steps required for VEGF-mediated signalling 18 . In our experiments, AIBP/HDL 3 treatment reduced VEGF-induced VEGFR2 dimerization and endocytosis as well as phosphorylation of VEGFR2, AKT, FAK (also known as PTK2), SRC, and to a lesser degree of ERK1 (also known as MAPK3) and ERK2 (also known as MAPK1) ( Fig HUVECs were pre-incubated with 50 mg ml 21 HDL 3 , 0.1 mg ml 21 AIBP or 50 mg ml 21 HDL 3 1 0.1 mg ml 21 AIBP for 4 h. Cells were stained for nuclei (blue, 49,6-diamidino-2-phenylindole (DAPI)) and for lipid rafts (red, cholera toxin B (CTB) 1 anti-CTB antibody). Scale bar, 10 mm. b, The area of lipid rafts per cell. Mean 6 s.e.; n 5 10; **P , 0.01; NS, P 5 0.08. c, Effect of human AIBP and HDL 3 on CAV1 and VEGFR2 surface localization. HUVECs were incubated with AIBP and/or HDL 3 as in a, fixed and stained with antibodies to CAV1 and VEGFR2. Images were captured using TIRF microscopy ( Supplementary Fig. 6 ) and Pearson's coefficient was calculated to assess surface co-localization of VEGFR2 with CAV1. Mean 6 s.e.; n 5 38-50; ***P , 0.001. d, VEGFR2 and CAV1 localization to lipid rafts. HUVECs were incubated with 20 mg ml 21 cholesterol-MbCD for 6 h, followed by a 1-h incubation with or without 50 mg ml 21 HDL 3 1 0.1 mg ml 21 AIBP, or a 30-min incubation with 10 mM MbCD. HUVEC lysates were separated into lipid rafts and non-lipid rafts fractions by ultracentrifugation, run on SDS-PAGE and blotted with VEGFR2 and CAV1 antibodies. e, Effect of human AIBP and HDL 3 on VEGFR2 dimerization. HUVECs were pre-incubated with HDL 3 and/or AIBP as in a, followed by a 20-min stimulation with 50 ng ml 21 VEGF. Cells were treated with a crosslinking reagent, lysed and immunoprecipitated with a VEGFR2 antibody. Monomers and crosslinked dimers of VEGFR2 were visualized on western blot. f, Effect of human AIBP and HDL 3 on VEGFR2 endocytosis. HUVECs were pre-incubated with or without 50 mg ml 21 HDL 3 1 0.1 mg ml 21 AIBP for 4 h, then stimulated with 50 ng ml 21 VEGF for 20 min, fixed and stained with antibodies to VEGFR2 (red) and the early endosome marker EEA1 (green). Yellow and white arrows point to the surface and endosomal localization of VEGFR2. Red dotted line traces cell contour. Scale bar, 10 mm. g, Effect of human AIBP and HDL 3 on VEGFR2 signalling. HUVECs were pre-incubated with HDL 3 and/or AIBP as in a, followed by a 20min stimulation with 50 ng ml 21 VEGF. Total cell lysates were run on SDS-PAGE and probed as indicated.
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reversed inhibition of VEGFR2, FAK and AKT phosphorylation in AIBP/HDL 3 -treated cells ( Supplementary Fig. 11 ). Consistent with the effect on VEGF signalling, HUVEC migration towards a VEGF cue was significantly reduced in AIBP/HDL 3 -treated cells (Supplementary Fig. 12 ). These results indicate that AIBP facilitates cholesterol efflux from HUVECs to HDL and that cholesterol depletion of the plasma membrane disrupts lipid rafts and VEGF signalling and inhibits VEGF-induced angiogenesis. AIBP is evolutionary conserved between Drosophila, zebrafish, mouse and human ( Supplementary Fig. 13a ). Zebrafish have two genes, here termed aibp1 (also known as apoa1bp) and aibp2 (also known as yjefn3), that code for the Aibp1 and Aibp2 proteins, respectively ( Supplementary Fig. 13b ). The aibp2 expression in 24-36 h postfertilization (h.p.f.) zebrafish embryos shows a clear segmental pattern, co-localizing with the somite marker myod1 ( Fig. 3a and Supplementary Fig. 14) . By 48 h.p.f., when segmental angiogenesis is completed, aibp2 is no longer expressed in somites.
Both zebrafish Aibp2 and zebrafish Aibp1 bound to human apoA-I and to the HDL in human plasma, but only Aibp2 was effective in promoting cholesterol efflux from HUVECs to HDL 3 ( Supplementary  Figs 15, 16 ). Zebrafish embryos injected with antisense morpholino oligonucleotides targeting aibp2 translation sites had increased levels of free (unesterified) cholesterol, whereas injections of aibp1 or scrambled control morpholino oligonucleotide did not result in any changes (Fig. 3b , c and Supplementary Fig. 17 ). Thus, we focused on aibp2. Using the polarity-sensitive fluorescent probe Laurdan, we observed a higher membrane lipid order in the areas of growing segmental arteries (SeA) corresponding to tip cells compared to stalk cells ( Fig. 3d, e ), suggesting a higher content of lipid rafts in tip cells, which may positively regulate zebrafish Vegfr2 (encoded by gene kdrl) signalling. The membrane lipid order was increased in the SeA of aibp2 morphants compared to controls, and the difference between tip and stalk cells was lost. To test the hypothesis that Aibp2-mediated cholesterol efflux regulates membrane order in growing SeA, we injected aibp2 morphants with human HDL 3 or with bovine serum albumin (BSA). Adding an excess of HDL 3 -to promote cholesterol efflux and to override the Aibp2 deficiency-annulled the increase in membrane order in SeA of aibp2 morphants, and a spatially indiscriminate HDL 3 excess equalized the membrane order in tip and stalk cells. Adding an excess of BSA had no effect on the membrane order in aibp2 morphants. Lysates of aibp2 knockdown embryos displayed increased phosphorylation of Vegfr2, Akt and Src, and decreased phosphorylation of Erk1 ( Fig. 3f and Supplementary Figs 18, 19 ). These results suggest that zebrafish Aibp2 regulates cholesterol levels, the membrane lipid order and Vegfr2 signalling and, thus, may control angiogenesis.
Indeed, injection of morpholino oligonucleotides targeting aibp2 translation or splicing sites into one-cell stage embryos of Tg(fli1:egfp) y1 zebrafish, which express eGFP in endothelial cells 19 , resulted in remarkable dysregulation of angiogenesis, with profound ectopic branching of SeA and sprouting of subintestinal veins (SIV) ( Fig. 3g and Supplementary  Figs 20, 21 ). The aibp2 knockdown was validated in western blot (Fig. 3f ). The ectopic branching of SeAs in aibp2 morphants was partially rescued by forced expression of aibp2 mRNA lacking the morpholino oligonucleotide target site (Fig. 3h ).
The aibp2 expression pattern ( Fig. 3a ) resembles that of type 3 semaphorins, non-cell-autonomous repellent cues that guide the patterning of developing SeAs through endothelial-specific Plexin D1 receptors 20 . To determine the cell autonomy of the Aibp2 effect on angiogenesis, we performed cell-transplantation experiments, using Tg(fli1:egfp) y1 donors. Fluorescent endothelial cells from wild-type donors found in non-fluorescent aibp2 morphants displayed excessive branching and filopodial projections, whereas fluorescent endothelial cells from aibp2 morphant donors found in wild-type recipients had normal morphology (Fig. 4a, b) . In a gain-of-function experiment, overexpression of Aibp2 inhibited SeA sprouting from the dorsal aorta 
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and normal growth of sprouted SeA ( Supplementary Fig. 22 ). These results suggest a role for Aibp2 as a repellent molecule whose function depends on the milieu surrounding endothelial cells but not on Aibp2 expression in the endothelial cells themselves. The loss of zebrafish Aibp2 resulted in increased expression of genes involved in angiogenesis, such as tie2, vegfr2, vegfr3 and fli1 ( Supplementary Figs 23, 24 ). Thus, in addition to the effect of Aibp2 on the membrane lipid order and Vegfr2 signalling (Figs 3d-f), Aibp2 also affects expression of angiogenic genes.
To further validate that effective cholesterol efflux is required for normal angiogenesis, we knocked down zebrafish cholesterol transporters abca1 and abcg1 (refs 21, 22) and observed higher levels of free cholesterol, increased levels of phosphorylated Akt, Vegfr2 and Src, and dysregulated SeA and SIV angiogenesis (Figs 3f, 4c and Supplementary Figs 19, [25] [26] [27] , closely reproducing the angiogenesis defects of aibp2 morphants. Individual knockdown of both abca1 and abcg1 suggested a dominant role of abca1 in embryonic angiogenesis ( Supplementary Fig. 28 ). In contrast to the aibp2 non-cell-autonomous regulation of angiogenesis, fluorescent endothelial cells from abca1 abcg1 morphant donors found in wild-type recipients displayed excessive SeA branching (Figs 4a, b) , confirming that cholesterol efflux from endothelial cells is required to restrain ectopic angiogenesis. Overexpression of Aibp2-mCherry in somites resulted in inhibition of SeA growth, which was rescued by knocking down abca1 and abcg1 (Figs 4d, e ). These results provide additional evidence that expression of zebrafish Aibp2 limits blood vessel growth and also suggest that zebrafish Abca1-and/or Abcg1-mediated cholesterol efflux is required for the effect of Aibp2 on angiogenesis.
On the basis of our results, we propose that there is an additional level of paracrine regulation of the VEGFR2 pathway in which cholesterol efflux and associated reduction of ordered membrane microdomains/lipid rafts interfere with the VEGFR2 membrane localization, dimerization, endocytosis and signalling. Because in 24 h.p.f. zebrafish aibp2 mRNA is highly expressed in somites, but not in the inter-somitic spaces where SeA grow, it is likely that zebrafish Aibp2-mediated cholesterol efflux inhibits Vegfr2 signalling in a site-specific manner to prevent lateral protrusions from stalk and tip cells and restrains ectopic SeA growth into somites ( Supplementary Fig. 1) .
The role of cholesterol-efflux mechanisms in protecting against endothelial dysfunction, in particular in hypercholesterolemic animals prone to the development of atherosclerosis, has been reported 10, 23 . However, our study is the first to demonstrate the role of AIBP in promoting cholesterol efflux from endothelial cells to HDL and the importance of this mechanism in regulation of angiogenesis. In contrast to the apoA-I-containing HDL, apoB-containing low-density lipoprotein and very-low-density lipoprotein deliver cholesterol and other lipids to the cell and, thus, are positioned to promote angiogenesis. Interestingly, a recent paper finds the opposite; that apoB lipoproteins negatively regulate angiogenesis in zebrafish embryos 24 . The authors suggest a mechanism in which the apoB protein, but not the lipid components within apoB-containing lipoproteins, is responsible for transcriptional regulation of Vegfr1, a soluble decoy receptor for VEGF. Our experiments uncovered a different, lipid-mediated mechanism in which effective cholesterol efflux is a critical process that ensures proper angiogenesis and Aibp secreted by the surrounding tissues serves as an important negative regulator of angiogenesis.
METHODS SUMMARY
Human and zebrafish AIBP were used in cholesterol efflux, angiogenesis and cellular assays as described 10, 23, 25 . In vivo angiogenesis was monitored in Tg(fli1:egfp) y1 zebrafish with aibp2 and/or abca1 and abcg1 knockdown or forced aibp2 expression. 
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METHODS
Cloning of human and zebrafish AIBP, recombinant protein expression and purification and antibody production. Zebrafish aibp2 (NCBI Gene ID:557840) and aibp1 (NCBI Gene ID:436891) were cloned from zebrafish brain complementary DNA using primers: CCGGAATTCCATGTTGGGGGTTCGAGCTCTG (59) and CGCGGATCCTCAGTTGAGCTGAAACACACACTC (39) for aibp1 and CCGGAATTCCGCCACCATGAACCACAGCTCCAACG (59) and CGCGGAT CCCGCAGTTCTATAATACATTCTGTGC (39) for aibp2. The fragments were cloned in frame into pFLAG-CMV4 (Sigma). Human APOA1BP (Gene ID: 128240) was cloned from HEK293 cell cDNA using primers: CCGGAATTCCAT GTCCAGGCTGCGGGCGCTGCTGGGCCTCG (59) and CGGGGTACCTCAC TGCAGACGATAGACACACTC (39) . For expression of AIBP proteins, the genes were cloned in frame into pHUE vector 26 (provided by T. Handel), expressed in BL21 DE3 competent cells (Invitrogen) and purified with a Ni-NTA agarose resin column (Qiagen). Deubiquitinase (DUB) expressed in pHUE was used as a negative control in experiments with recombinant AIBP. To produce a zebrafish Aibp2 antibody, recombinant Aibp2 was mixed with complete Freund's adjuvant (Sigma) and injected subcutaneously into a guinea pig. The guinea pig was boosted three more times. Post-immune plasma was compared with pre-immune plasma from the same animal and used in western blot to detect Aibp2 in zebrafish lysates ( Supplementary Fig. 18 ). The specificity of the antibody was confirmed by adding excess of recombinant Aibp2 to the antibody, which prevented its binding to a specific band on the western blot. Cholesterol efflux. A cholesterol efflux assay was performed as described 23, 27 , with modifications. In brief, HUVECs (ATCC) were loaded with 2 mCi ml 21
3
H-cholesterol, and cholesterol efflux was initiated by the addition of 0.2% BSA/ endothelial cell basal medium (EBM) with 50 mg ml 21 HDL 3 (isolated from normolipidemic human plasma by ultracentrifugation), in the presence or absence of 0.2 mg ml 21 zebrafish Aibp2, Aibp1, or human AIBP. DUB, replacing AIBP, was used as a negative control. Background, nonspecific release of 3 H-cholesterol was measured in absence of HDL. After 1-6 h of incubation, the medium was collected and counted in a liquid scintillation counter LS 6500 (Beckman Coulter). The cells were extracted with 2-propanol, and the lipid extract was added to ScintiVerse BD Cocktail (Fisher) and counted. Cholesterol efflux was expressed as a percentage of 3 H counts in the medium compared to combined 3 H counts in the cells and the medium. Background, nonspecific release of 3 H from the cells was subtracted. ABCG1 knockdown. Both negative control and ABCG1 siRNA oligonucleotides were from Ambion. HUVECs were plated in 6-well plates at 5 3 10 5 cells per well and transfected with 66.6 nM siRNA using SuperFect Transfection Reagent (Qiagen) as described in the manufacturer's protocol. Two days after transfection, cells were washed and used in an efflux assay. Two additional wells of transfected cells were used to confirm ABCG1 knockdown in western blot using an antibody from Novus Biologicals. AIBP/HDL 3 -HUVEC binding assay. Human AIBP and HDL 3 were biotinylated with EZ-Link Sulfo-NHS-Biotin (Thermo Scientific) according the manufacturer's protocol. Binding of biotinylated human AIBP or biotinylated HDL 3 to HUVECs was assessed by a chemiluminescent binding assay as described in ref. 28 In vitro angiogenesis assay. The angiogenesis assay was carried out as described in refs 25 and 29. Growth factor reduced Matrigel (BD Biosciences) was thawed at 4 uC overnight and diluted with an equal volume of serum-free EBM medium (Lonza). Each well of 96-well plates was coated with 50 ml diluted Matrigel and incubated at 37 uC for 1 h. HUVECs were serum-starved and then pre-incubated with HLD 3 and/or human AIBP. Cells were collected and added to Matrigelcoated plates at 1 3 10 4 cells per well in EBM, in the presence or absence of 20 ng ml 21 VEGF (R&D Systems). Following a 12-h incubation, tubular structures were imaged with a phase contrast microscope. Free cholesterol measurements in HUVECs. HUVEC cholesterol levels were measured in cellular lipid extracts using a colorimetric assay (BioVision) as previously described 14 .
Aortic ring neovascularization assay. The method was adopted from ref. 30 , with modifications. Thoracic aorta was isolated from a 6-week-old male C57BL/6 mouse or an age-and gender-matched Abcg1 2/2 mouse (provided by C. Hedrick), cleaned from surrounding fat and connective tissue and sliced into 1-mm-long rings. The aortic rings were placed in wells of a 48-well plate containing solidified Matrigel and then covered with additional Matrigel. Small wells were made in Matrigel approximately 0.5 mm from aortic rings and 50-ml aliquots of Matrigel containing 1 3 10 5 HEK293 cells transfected with mCherry (negative control), zebrafish Aibp2 or human AIBP were placed in these wells. After 10 min, each well was filled with EBM medium supplemented with 10 ng ml 21 VEGF and the plates were incubated at 37 uC for 6 days. Media were changed every 2 days. The rings were photographed in phase contrast using a Nikon Eclipse Ti microscope. Visualization of lipid rafts with cholera toxin B. HUVECs were plated on glass coverslips and pre-incubated with 50 mg ml 21 HDL 3 , 0.1 mg ml 21 human AIBP or 50 mg ml 21 HDL 3 plus 0.1 mg ml 21 human AIBP for 4 h. Cells were washed once with medium before the addition of 1 mg ml 21 Alexa Fluor 594-labelled CTB (Invitrogen). Cells were incubated for 15 min at 4 uC, washed with PBS and then incubated for 15 min at 4 uC with an anti-CTB antibody (EMD Chemicals) to crosslink CTB and lipid rafts. After washing with PBS, cells were fixed in 4% PFA for 20 min at 4 uC, mounted with a Prolong Antifade Kit with DAPI (Invitrogen) and images were captured with a Leica DM IRE2 fluorescent microscope. Cell fractionation. Lipid rafts (light membrane fractions) were isolated using a detergent-free, discontinuous gradient ultracentrifugation method 14 . In brief, HUVECs were washed twice with ice-cold PBS and cells were scraped from the plate in 0.5 M sodium carbonate buffer (pH 11.0) containing a protease inhibitor cocktail (Sigma), homogenized and sonicated three times for 10 s. Samples were adjusted to 45% sucrose by adding a 90% sucrose solution in MBS (25 mM 2-(N-morpholino)ethanesulfonic acid, 0.15 M NaCl, pH 6.5) and placed into ultracentrifugation tubes. A 5-35% sucrose discontinuous gradient was formed above the sample, followed by ultracentrifugation at 35 3 10 3 r.p.m. for 18 h at 4 uC in a SW-41 rotor (Beckman). Ten 1-ml fractions were collected from the top to the bottom of each gradient. The lipid rafts fraction (fraction 5) and the nonlipid rafts fraction (fraction 10) were used for further analysis, which included measurements of protein concentration and immunoblotting. Thirty microlitres of lipid rafts and non-lipid rafts fractions (adjusted to load equal protein concentrations of each sample) were run on SDS-PAGE, transferred to polyvinylidene difluoride (PVDF) membranes and blotted with the indicated antibodies. CAV1 and VEGFR2 co-localization. HUVECs plated on chamber coverglass (Lab-Tek II) were incubated for 4 h with 0.1 mg ml 21 human AIBP, 50 mg ml 21 HDL 3 or 0.1 mg ml 21 AIBP 1 50 mg ml 21 HDL 3, and the cells were washed with PBS and fixed with warm 4% PFA for 15 min at room temperature (24 uC) . HUVECs were permeabilized, blocked, and incubated with anti-CAV1 (BD Biosciences) and anti-VEGFR2 (Cell Signaling Technology) antibodies, followed by incubation with anti-mouse IgG-Alexa Fluor 488 and anti-rabbit IgG-Cy3 antibodies. Images were captured using a Nikon Eclipse Ti inverted fluorescent microscope operating in TIRF mode. Raw TIFF images of CAV1 and VEGFR2 were analysed using JACoP algorithm 31 in Image J. Co-localization was quantified using Pearson's coefficient. VEGFR2 endocytosis. HUVECs were incubated for 4 h with 0.1 mg ml 21 human AIBP, 50 mg ml 21 HDL 3 or 0.1 mg ml 21 human AIBP 1 50 mg ml 21 HDL 3 , followed by a 20-min incubation with 50 ng ml 21 VEGF. Cells were fixed and stained with antibodies against VEGFR2 and the early endosomal marker EEA1-FITC (BD Biosciences). Images were captured with a Nikon Eclipse Ti inverted fluorescent microscope. VEGFR2 and EEA1 co-localization was quantified using Pearson's coefficient with the JACoP plugin loaded to ImageJ 31 . VEGFR2 dimerization assay. The assay was carried out as described in ref. 32 . Two days after plating 1 3 10 6 HUVECs in a 10-cm dish, the cells were starved overnight in 0.5% FBS-EBM. The next day, cells were incubated with human AIBP and/or HDL 3 , followed by a 20-min incubation with 50 ng ml 21 VEGF and then crosslinked with 1 mg ml 21 bis-sulfosuccinimidyl (Thermo Scientific) for 30 min on ice. Cell lysates were immunoprecipitated with an anti-VEGFR2 antibody
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immobilized on agarose beads. The beads were washed and the eluted samples were run on SDS-PAGE, followed by immunoblotting with the VEGFR2 antibody. HUVEC migration assay. Serum-starved HUVECs were pretreated with 50 mg ml 21 HDL 3 , 0.2 mg ml 21 human AIBP or 50 mg ml 21 HDL 3 1 0.2 mg ml 21 human AIBP for 4 h at 37 uC in 5% lipoprotein-deficient serum (LPDS) and EBM (Lonza), collected from the plate, washed, re-suspended in 5% LPDS/EBM and added to the transwell (8 mm pore size). VEGF was added to the lower chamber at 20 ng ml 21 . Following a 4-h incubation, the transwell membranes were fixed in ice-cold methanol for 10 min and stained with filtered 0.5% Crystal Violet for 10 min, and transmigrated cells were counted. Zebrafish. Wild-type AB and transgenic Tg(fli1:egfp) y1 and Tg(flk1:ras-cherry) s896 zebrafish lines 19, 33 were provided by D. Traver and N. Chi (UCSD). Zebrafish were maintained as previously described 34 , and all experimental procedures were approved by the UCSD Institutional Animal Care and Use Committee. Confocal microscopy. Confocal imaging was carried out as previously described 35 .
In brief, anaesthetized zebrafish embryos (treated at 24 h.p.f. with 0.003% 1-phenyl 2-thiourea) were housed in a sealed chamber (Invitrogen) in a small drop of 0.02% tricaine (Sigma) containing E3 embryonic medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl 2 , 0.33 mM MgSO 4 and 0.1% methylene blue) and imaged using a Nikon C1si confocal microscope. Z-stacks were acquired with a 1-3-mm step, and images were three-dimensionally rendered and analysed using Imaris software (Bitplane Measuring membrane lipid order with polarity-sensitive probe. The experiments were carried out as described in refs 36 and 37. In brief, live Tg(flk1:rascherry) s896 zebrafish embryos were incubated with 5 mM Laurdan (Invitrogen) at 28 uC for 30 min. The concentration of a Laurdan stock solution was measured using attenuance at 365 nm and an extinction coefficient of 19,000 cm 21 M 21 .
After incubation with Laurdan, embryos were incubated with E3 medium for additional 30 min, fixed in PFA for 4 h at room temperature, de-yolked and embedded in 1% low-melting-temperature agarose for imaging. Images were captured with a Leica SP5 confocal/multiphoton system, using a water immersion 320 objective. The confocal mode was used to capture mCherry fluorescence and the multiphoton mode was used to capture Laurdan images (ex., 800 nm, em., 400-460 nm and 470-530 nm) in the same embryos. The multiphoton results were displayed as pseudo-coloured GP (a measure of the membrane lipid order) images, derived from Laurdan ratiometric measurements and using a ImageJ plug-in as described 36 . The quantitative data were obtained by measuring GP values in the areas corresponding to tip cells (top one-third of the SeA length), stalk cells (bottom two-thirds of the SeA length) and the dorsal aorta in several individual, mCherry-masked z-sections. This method ensured that GP values were derived only from endothelial cells (for example, from the areas where mCherry was in focus in each z-section). The GP images in Fig. 3d were composed each from four to five individual z-sections, with a minimal overlap of mCherry-masked GP images. WISH. WISH was carried out as described [38] [39] [40] . In brief, wild-type embryos or morphants at indicated developmental stages were fixed with 4% PFA and the embryos older than 24 h.p.f. were permeabilized with 10 mg ml 21 proteinase K (Roche). Subsequently, the embryos were pre-hybridized at 70 uC for 4-6 h, and then hybridized with a digoxigenin-labelled aibp2 antisense probe at 65 uC for 2 days. Both the control sense and anti-sense RNA probes were directly synthesized from aibp2 full-length gene using a Roche T7/SP6 RNA or Ambion T3 RNA synthesis kit. After extensive wash, hybridized RNA was detected by immunohistochemistry using an alkaline-phosphatase-conjugated antibody against digoxigenin (Roche) and a chromogenic substrate nitro blue tetrazolium (NBT) (Sigma) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) 38 (Sigma). A similar procedure was performed with tie2, vegfr2, vegfr3, fli1 and cdh5 probes. Double WISH was performed as described 41 . Both digoxigenin-labelled aibp2 and fluoresceinlabelled myod1 were hybridized with the same embryos. The embryos were then first incubated with alkaline-phosphatase-conjugated anti-fluorescein antibody, and fast red (Roche) was used as a substrate. Subsequently, the embryos were washed, fixed with 4% PFA and incubated with anti-digoxigenin antibody conjugated alkaline phosphatase, and then NBT/BCIP was used as a chromogenic substrate. Transplantation experiments. Cell transplantation was performed as described 39 , with different combinations of donors and recipients as indicated in Fig. 4a . Donor embryos were of the Tg(fli1:egfp) y1 origin, and recipient embryos were of the wildtype origin. At the one-cell stage, donor Tg(fli1:egfp) y1 embryos were injected with rhodamine-labelled dextran (mini-ruby, Invitrogen) as a lineage tracer. At the sphere stage (approximately 4 h.p.f.), embryos were dechorionated by 0.4 mg ml 21 pronase (Sigma) and transferred to agarose wells (Adaptive Science Tools). Approximately 20-40 cells from the margin of a donor embryo were transferred to the margin of a recipient embryo. The recipient embryos were subsequently grown at 28 uC and imaged at 72 h.p.f. Endothelial cells in chimaeric zebrafish originating from donor embryos were visualized by their green fluorescence using a Leica M165FC fluorescent stereoscope. For detailed analysis, images were captured using a Nikon C1si confocal microscope. Numbers of ectopic branches in each fluorescent SeA were counted. Real-time PCR. Real-time PCR was performed using a Rotor Gene Q PCR machine (Qiagen). Real-time PCR master mix Platinum SYBR Green qPCR SuperMix was from Invitrogen. The primers were synthesized by Integrated DNA Technologies. The PCR program was: 50 uC for 2 min (UDG incubation), 95 uC for 2 min, 40 cycles of: 95 uC for 15 s, 60 uC for 1 min. Primer sequences: fli1: forward CTTGGCACGTTGCCTTGATAAG, reverse CCTTCATATCTGAGAG TGATCCC; tie2: forward GCGATGGATGGCAATAGAGT; reverse CGACAGC AGGATCTGAGAGA; vegfr2: forward TCCACGAGGGTGGGCAGTCA, reverse AGACGGGTGGTGTGGAGTAACGA; kdrb: forward TGCCCACATGGAGCT GCTAGCA, reverse TGTGGCACATTCAACCACATGAGC; actb1: forward CT CTTCCAGCCTTCCTTCCT, reverse GGTTGGTCGTTCGTTTGAAT. Immunoblot of zebrafish lysates. Zebrafish were lysed on ice with a lysis buffer (50 mM Tris-HCl, pH 7.5, 4 mM sodium deoxycholate, 1% Triton X-100, 150 mM NaCl, 1 mM EDTA and a protease inhibitor cocktail from Sigma). Protein content was determined with a DC protein assay kit (BioRad) and equal protein amounts of the cell lysates were run on a 4-12% Bis-Tris SDS-PAGE with MOPS buffer (Invitrogen) and then transferred to a PVDF membrane (Invitrogen). The blots were probed with appropriate antibodies against specific phosphorylated and nonphosphorylated proteins (Cell Signaling Technology), secondary antibodies conjugated with horseradish peroxidase and developed using a SuperSignal West Dura substrate (Pierce). Filipin staining. Filipin staining of embryos was performed as described 42 . Zebrafish were fixed with 4% PFA overnight at 4 uC. The fixed fish were incubated overnight with 0.05% filipin (Sigma) in PBS with 1% sheep serum, and then washed three times with PBS. Images were captured immediately with a Leica M165FC fluorescent stereoscope and quantified. Total lipid extraction and free cholesterol measurements in zebrafish. Total lipid was extracted from zebrafish embryos as we previously described 28 . In brief, trunk/tail segments were dissected from 50 24 h.p.f. embryos and pooled together. The tissue was homogenized and supplemented with 50 mg stigmasterol, an internal standard to control for recovery of extracted sterols. Total lipid extraction was performed with 1:2 methanol/dichloromethane. No saponification of cholesterol esters was performed because the goal of this study was to measure free cholesterol, the form of cholesterol transferred from the cells via ABC transporters to apoA-I/HDL. Cholesterol and stigmasterol were measured with a Shimadzu GC-2014 gas chromatograph using a 30 m 3 0.25 mm (i.d.) ZB-5HT Inferno capillary column, film thickness 0.2 mm (Phenomenex). Cholesterol levels were normalized to protein and then to the levels in embryos injected with control morpholino oligonucleotides.
